Cognanous
Is this your company? Claim this profile
Contract Research Organization
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Drug Product
Advanced Modalities
Consultants & Advisory Services
Company Overview
About
Cognanous (doing business as Cognano) is a US-based biotech company that leverages alpaca and shark antibody data combined with AI/LLM technology to discover novel biomarkers for drug discovery. The company developed IBMET (Inverse Biomarker Exploring Technology) to identify novel antigens and therapeutic candidates, focusing on biomarker discovery rather than contract manufacturing or drug development services.
Key Expertise
VHH antibody biomarker discovery, IBMET technology, AI-driven drug discovery seeds, alpaca/shark antibody databases
Quick Facts
HQ:United States
Founded:2018
Consulting Services
Cognanous — Strategic & planning services, Support functions
Business Development & Licensing
Expertise
Business Development & Strategy
Commercial & Creative services
Corporate & Commercial Strategy
- Industry experience
- 8 years
- Engagement types
- consulting
Capabilities & Services
Markets Served
North America
Manufacturing Facilities
1 site worldwide
Cognanous - United States Facility
United States
Site Capabilities
3 capabilitiesGene Therapy
Cell Therapy
mRNA